---
figid: PMC11232665__ijmm-54-02-05395-g02
figtitle: Mechanism of metformin in intervertebral disc degeneration
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11232665
filename: ijmm-54-02-05395-g02.jpg
figlink: /pmc/articles/PMC11232665/figure/F3
number: F3
caption: Potential mechanism of metformin in intervertebral disc degeneration. In
  MSCs, metformin promotes formation of MVB or amphipathic bodies, induces phosphorylation
  of SNAP29 and promotes EV release. In the NP, high doses of metformin reduce AMP
  by inhibiting mitochondrial complex I; low doses of metformin may bind to PEN2,
  and both pathways activate AMPK thereby enhancing autophagy. Autophagy reduces the
  expression of p16INK4a, SA-β-gal, p21WAF1 and p-p53 and inhibits senescence; autophagy
  also inhibits Bax, Caspase and leads to barrier function. In addition, autophagy
  reduces the activation of cGAS/STING signaling pathway and phosphorylation of P65,
  thereby reducing COX2 and the inflammatory mediator PGE2. In AFSCs, metformin inhibits
  extracellular migration of HMGB1 and decreases expression of inflammatory mediators.
  Figure adapted from Server Medical Art (https://smart.servier.com/). AFSC, anulus
  fibrosus stem cells; cGAS, cyclic GMP-AMP synthase; COX2, cyclooxygenase-2; EV,
  extracellular vesicle; HMGB1, high mobility group box 1; MSC, mesenchymal stem cell;
  NP, nucleus pulposus; PINK, PTEN-induced kinase; SNAP, synaptosome associated protein;
  STING, stimulator of interferon genes; MVB, multivesicular body; p-, phosphorylated;
  SA-β-gal, senescence-associated β-galactosidase; WAF1, wild-type p53 activated fragment-1;
  PGE2, prostaglandin E2
papertitle: 'Metformin prevents the onset and progression of intervertebral disc degeneration:
  New insights and potential mechanisms (Review)'
reftext: Wenzhi Yang, et al. Int J Mol Med. 2024 Aug;54(2).
year: '2024'
doi: 10.3892/ijmm.2024.5395
journal_title: International Journal of Molecular Medicine
journal_nlm_ta: Int J Mol Med
publisher_name: D.A. Spandidos
keywords: metformin | type 2 diabetes mellitus | intervertebral disc degeneration
  | nucleus pulposus | mechanism | treatment
automl_pathway: 0.9591005
figid_alias: PMC11232665__F3
figtype: Figure
redirect_from: /figures/PMC11232665__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11232665__ijmm-54-02-05395-g02.html
  '@type': Dataset
  description: Potential mechanism of metformin in intervertebral disc degeneration.
    In MSCs, metformin promotes formation of MVB or amphipathic bodies, induces phosphorylation
    of SNAP29 and promotes EV release. In the NP, high doses of metformin reduce AMP
    by inhibiting mitochondrial complex I; low doses of metformin may bind to PEN2,
    and both pathways activate AMPK thereby enhancing autophagy. Autophagy reduces
    the expression of p16INK4a, SA-β-gal, p21WAF1 and p-p53 and inhibits senescence;
    autophagy also inhibits Bax, Caspase and leads to barrier function. In addition,
    autophagy reduces the activation of cGAS/STING signaling pathway and phosphorylation
    of P65, thereby reducing COX2 and the inflammatory mediator PGE2. In AFSCs, metformin
    inhibits extracellular migration of HMGB1 and decreases expression of inflammatory
    mediators. Figure adapted from Server Medical Art (https://smart.servier.com/).
    AFSC, anulus fibrosus stem cells; cGAS, cyclic GMP-AMP synthase; COX2, cyclooxygenase-2;
    EV, extracellular vesicle; HMGB1, high mobility group box 1; MSC, mesenchymal
    stem cell; NP, nucleus pulposus; PINK, PTEN-induced kinase; SNAP, synaptosome
    associated protein; STING, stimulator of interferon genes; MVB, multivesicular
    body; p-, phosphorylated; SA-β-gal, senescence-associated β-galactosidase; WAF1,
    wild-type p53 activated fragment-1; PGE2, prostaglandin E2
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MSC
  - SLC25A37
  - NPC1
  - APRT
  - MFAP1
  - DNAH8
  - HMGB1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - CDKN2A
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - TP53
  - TP63
  - TP73
  - SNAP29
  - IL1A
  - IL1B
  - TNF
  - PTGS2
  - CGAS
  - STING1
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - Metformin
  - AMP
  - TNF-a
  - PGE2
---
